Delivery of methotrexate executed by engineered polymeric micelles intended to improve chemotherapy

Journal of Biomaterials and Tissue Engineering

Volumn 4, Issue 9, 2014, Pages 700-709

  Kumar, Bijay ^a   Meher, Jaya Gopal ^a   Gupta, Annie ^a   Pawar, Vivek K ^a   Singh, Yuvraj ^a   Chourasia, Manish K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Acute toxicity; Cytotoxicity; Methotrexate; Pluronic F127; Polymeric micelles; Sodium dodecyl sulfate

Indexed keywords

DODECYL SULFATE SODIUM; METHOTREXATE; PHOSPHATIDYLCHOLINE; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYDRATION; MICELLE; MOUSE; MTT ASSAY; NONHUMAN; PARTICLE SIZE; PROTON NUCLEAR MAGNETIC RESONANCE; THERMODYNAMICS; TOXICITY TESTING; ULTRASOUND; ULTRAVIOLET SPECTROPHOTOMETRY; ZETA POTENTIAL;

MUS;

EID: 84924652727     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2014.1219     Document Type: Article

References (31)

1. V. Y. Alakhov, E. Y. Moskaleva, E. V. Batrakova, and A. V. Kabanov, Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 block copolymer. Bioconjugate Chem. 7, 209 (1996).
2. A. V. Kabanov, E. V. Batrakova, and V. Y. Alakhov, Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control Release82, 189 (2002).
3. H. M. Aliabadi and A. Lavasanifar, Polymeric micelles for drug delivery. Expert. Opin. Drug Deliv.3, 139 (2006).
4. S. Asthana, A. K. Jaiswal, P. K. Gupta, V. K. Pawar, A. Dube, and M. K. Chourasia, Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules. Antimicrobial Agents and Chemotherapy57, 1714 (2013).
5. B. I. F. Vroman, Ch. Jérôme, and V. Préat, PEGylated quaternized copolymer/DNA complexes for gene delivery. Int. J. Pharm.344, 88 (2007).
6. E. V. Batrakova and A. V. Kabanov, Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J. Control Release130, 98 (2008).
7. K. R. Chaudhari, M. Ukawala, A. S. Manjappa, A. Kumar, P. K. Mundada, A. K. Mishra, R. Mathur, J. Monkkonen, and R. S. Murthy, Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier. Pharm. Res.29, 53 (2012).
8. A. Z. Chen, G. Y. Wang, S. B. Wang, L. Li, Y. G. Liu, and C. Zhao, Formation of methotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspensionenhanced dispersion by supercritical CO2. International Journal of Nanomedicine7, 3013 (2012).
9. J. R. Lopes and W. Loh, Investigation of self-assembly and Micelle polarity for a wide range of ethylene oxide-propylene oxide-ethylene oxide block copolymers in water. Langmuir14, 750 (1998).
10. A. V. Kabanov, E. V. Batrakova, and V. Y. Alakhov, Pluronics block copolymers for overcoming drug resistance in cancer. Adv. Drug Deliv. Rev.54, 759 (2002).
11. A. V. Kabanov, E. V. Batrakova, and V. Y. Alkhov, An essential relationship between ATP depletion and chemosensitizing activity of pluronicblock copolymers. J. Control. Rel.91, 74 (2003a).
12. Y. Kadam, U. Yerramilli, A. Bahadur, and P. Bahadur, Micelles from PEO–PPO–PEO block copolymers as nanocontainers for solubilisation of a poorly water soluble drug hydrochlorothiazide. Colloids and Surfaces B: Biointerfaces83, 49 (2011).
13. Z. A. Khan, R. Tripathi, and B. Mishra, Methotrexate: A detailed review on drug delivery and clinical aspects. Expert. Opinion on Drug Delivery9, 151 (2012).
14. S. C. Kim, D. W. Kim, Y. H. Shim, J. S. Bang, H. S. Oh, S. W. Kim, and M. H. Seo, In vivo evaluation of polymeric micellar paclitaxel formulation: Toxicity and efficacy. J. Controlled Release72, 191 (2001).
15. M. Kong and H. J. Park, Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohydr. Polym.83, 1303 (2011).
16. N. R. Kuznetsova, C. Sevrin, D. Lespineux, N. V. Bovin, E. L. Vodovozova, T. Meszaros, J. Szebeni, and C. Grandfils, Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer. Journal of Controlled Release: Official Journal of the Controlled Release Society160, 394 (2012).
17. Z. H. Leng, Q. F. Zhuang, Y. C. Li, Z. He, Z. Chen, S. P. Huang, H. Y. Jia, J. W. Zhou, Y. Liu, and L. B. Du, Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate. Carbohyd. Polym.98, 1173 (2013).
18. K. Letchford and H. M. Burt, Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics. Mol. Pharm.9, 248 (2012).
19. M. Li, K.-G. Neoh, R. Wang, B.-Y. Zong, J. Y. Tan, and E.-T. Kang, Methotrexate-conjugated and hyperbranched polyglycerolgrafted Fe3O4 magnetic nanoparticles for targeted anticancer effects. European Journal of Pharmaceutical Sciences48, 111 (2013a).
20. Y. Li, X. Xu, Y. Shen, C. Qian, F. Lu, and S. Guo, Preparation and evaluation of copolymeric micelles with high paclitaxel contents and sustained drug release. Colloids and Surfaces A: Physicochemical and Engineering Aspects429, 12 (2013b).
21. J. R. Lopes and W. Loh, Investigation of self-assembly and micelle polarity for a wide range of ethylene oxide-propylene oxide-ethylene oxide block copolymers in water. Langmuir14, 750 (1998).
22. M. V. F. Garinot, V. Pourcelle, F. Stoffelbach, A. desRieux, L. Plapied, I. Theate, H. Friechels, Ch. Jérôme, J. Marchand Brynaert, Y. J. Schneider, and V. Préat, PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J. Control. Release120, 195 (2007).
23. C.-F. Mu, P. Balakrishnan, F.-D. Cui, Y.-M. Y.-B. Yin Lee, H.-G. Choi, C. S. Yong, S.-J. Chung, C.-K. Shim, and D.-D. Kim, The effects of mixed MPEG–PLA/pluronic® copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials31, 2371 (2010).
24. V. K. Pawar, Y. Singh, J. G. Meher, S. Gupta, and M. K. Chourasia, Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery. J. Controlled Release183, 51 (2014).
25. J. P. Quinones, K. V. Gothelf, J. Kjems, A. Heras, C. Schmidt, and C. Peniche, Novel self-assembled nanoparticles of testosteronemodified glycol chitosan and fructose chitosan for controlled release. Journal of Biomaterials and Tissue Engineering3, 164 (2013).
26. M. Shahin, S. Ahmed, K. Kaur, and A. Lavasanifar, Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel. Biomaterials32, 5123 (2011).
27. V. P. Torchilin, Structure and design of polymeric surfactant-based drug delivery systems. J. Controlled Release73, 137 (2001).
28. P. Verma, J. G. Meher, S. Asthana, V. K. Pawar, M. Chaurasia, and M. K. Chourasia, Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer. Drug Delivery1–10 (2014).
29. W. Zauner, N. A. Farrow, and A. M. Haines, In vitro uptake of polystyrene microspheres: Effect of particle size, cell line and cell density. J. Control Release71, 39 (2001).
30. J. Zhao, S. Pispas, and G. Zhang, Effect of sonication on polymeric aggregates formed by poly(ethylene oxide)-based amphiphilic block copolymers. Macromolecular Chemistry and Physics210, 1026 (2009a).
31. J. Zhao, S. Pispas, and G. Zhang, Effect of sonication on polymeric aggregates formed by poly(ethylene oxide)-based amphiphilic block copolymers. Macromolecular Chemistry and Physics210, 1026 (2009b).